We are  investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Change Healthcare Inc. (“Change Healthcare” or the “Company”) (NASDAQ:CHNG) in connection with the proposed acquisition of the Company by UnitedHealth Group Incorporated (NYSE:UNH), a diversified health care company.  Under the terms of the merger agreement, Change Healthcare shareholders will receive only $25.75 in cash for each share of Change Healthcare common stock that they hold.

WeissLaw LLP is investigating whether Change Healthcare’s board acted in the best interest of Change Healthcare’s public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of the proposed acquisition of the Company, and whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com